trending Market Intelligence /marketintelligence/en/news-insights/trending/qnEEGQwfiBt6ZWRwzK_JrA2 content esgSubNav
In This List

Report: Blue Sea, CITIC Capital weigh sale of dental laboratory company DDS Lab

Podcast

Street Talk | Episode 98: Regulatory scrutiny having cooling effect on community bank M&A

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Podcast

Street Talk | Episode 97: Recessionary fears still keeping bank investors on the sidelines


Report: Blue Sea, CITIC Capital weigh sale of dental laboratory company DDS Lab

Private equity firms Blue Sea Capital LLC and CITIC Capital Partners are considering a sale of Tampa, Fla.-based dental laboratory company DDS Lab LLC, PE Hub Buyouts reported, citing sources familiar with the situation.

Moelis and Houlihan Lokey are acting as financial advisers to the sponsor-focused auction, sources said, adding that marketing materials were recently distributed to potential buyers.

DDS Lab is marketing about $20 million of its 2019 adjusted EBITDA on approximately $84 million of run-rate revenue, another source told the publication. The transaction could value between $200 million and $260 million based on the marketed EBITDA.

The process is still in its initial stages, two of the people said. It is unsure whether sponsor-backed businesses will submit bids for DDS. Industry players include Cressey & Co. LP's Dental Services Group, Welsh Carson Anderson & Stowe's National Dentex Corp., as well as Modern Dental Group Ltd., according to the report.

Blue Sea, a U.S. lower-middle-market investor, and CITIC Capital, the buyout unit of Chinese asset manager CITIC Capital Holdings Ltd., bought DDS Lab in June 2014. Financial terms were not disclosed.

Moelis representatives did not comment on the matter. Representatives from Blue Sea, CITIC, Houlihan Lokey and DDS did not immediately answer requests for comments sent by the news outlet.